ORCHID PHARMA
Intrinsic Value | Fundamental Analysis

BOM : 524372     NSE : ORCHPHARMA    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Good [Stock is Cheap]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : NA
May 25,2022
Price(EOD): β‚Ή 284.65
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: β‚Ή 1,161.37 Cr
Value of β‚Ή 1 Lac invested in ORCHID PHARMA
on May 25,2017 (price: β‚Ή 29.85)

β‚Ή 1 L

β‚Ή 9.54 L

1W : -5.5% 1M : -24.1% 1Y : -80%
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results
ORCHID PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
ORCHID PHARMA -5.5% -24.1% -80%
SUN PHARMACEUTICAL INDUSTRIES 3% 1.3% 31.9%
DIVIS LABORATORIES -16.2% -20.1% -9.3%
DR REDDYS LABORATORIES 9.6% 4.7% -16.9%
CIPLA 3.6% 1.9% 4.7%
GLAND PHARMA -11.4% -16.5% -9.6%
PIRAMAL ENTERPRISES -4.4% -14.3% 4.7%
CADILA HEALTHCARE 8.2% 7.4% -39.9%
TORRENT PHARMACEUTICALS 1.7% -3.5% -4.6%

FUNDAMENTAL ANALYSIS OF ORCHID PHARMA

 
Fundamentals Score
[ Q(TTM): Mar2022, Y: Mar2021
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF ORCHID PHARMA

 
Valuation Score
[As on : May 25,2022 ]

Ratio Consolidated
P/E
P/B
P/S
-
P/E Calculated based on EPS of -28.55
[ Mar2021 - Consolidated Results ]

1.78
P/B Calculated based on Book Value of 159.96
[ Mar2021 - Consolidated Results ]

2.08
P/S Calculated based on Revenues of 559.557 Cr
[ TTM - Consolidated Results ]

Financial Ratios →

Insights πŸ’‘ ORCHPHARMA is one of the potential top 21% undervalued companies ! Discover More →

FAIR VALUE OF ORCHID PHARMA

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
-77%
-34%
928%

Insights πŸ’‘ You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF ORCHID PHARMA


Insights πŸ’‘ There are 5% companies with bullish price momentum currently! Discover More →

ORCHID PHARMA vs SENSEX


Insights πŸ’‘ You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF ORCHID PHARMA

Year Debt/Equity ratio
Standalone Consolidated
2021
2020
2019
Avg_3yrs
0.66
0.71
-4.28
-0.97
0.69
0.74
-4.59
-1.05
[Last Annual Data : Mar2021]
Financial Ratios →

PLEDGED PROMOTER SHARES OF ORCHID PHARMA

Pledged Promoter Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF ORCHID PHARMA

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
10.38%
75.3%
55.85%
55.85%
48.99%
41.1%
-35.43%
-35.43%
QtrlyTrend
4
Latest Qtr: Mar2022
Quarterly Result Analysis →

Insights πŸ’‘ ORCHPHARMA is one of the top 44% companies with good quarterly result uptrend ! Discover More →

ORCHID PHARMA related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about ORCHID PHARMA


Is ORCHID PHARMA good for long term investment?

As on May 25,2022, the Fundamentals of ORCHID PHARMA look Poor and hence it may not be good for long term investment ! See Financial Performance of ORCHID PHARMA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is ORCHID PHARMA UnderValued or OverValued?

As on May 25,2022, ORCHID PHARMA is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of ORCHID PHARMA ?

As on May 25,2022, the Intrinsic Value of ORCHID PHARMA is Rs. 432.44 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 1,222.55
Fair Value [Median EV / Sales Model] : Rs. 432.44
Fair Value [Median Price / Sales Model] : Rs. 27.70
Median Fair Value of ORCHID PHARMA : Rs. 432.44

Is ORCHID PHARMA trading at a Premium or Discount?

As on May 25,2022, ORCHID PHARMA is trading at a Discount of -34% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z
ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z